InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,461.21
(
0.24%
)
US TECH 100
19,072.00
(
0.60%
)
Dow Jones
39,171.54
(
-0.61%
)
Brent Oil
85.17
(
-0.12%
)
Bitcoin
61,434.01
(
1.94%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

homeslice10

Send PM Follow Ignore
Followers 33
Posts 2891
Boards Moderated 0
Alias Born 01/24/2012

homeslice10

Re: Trader Joey post# 66436

Monday, 05/19/2014 11:52:39 PM

Monday, May 19, 2014 11:52:39 PM

Post# of 92948
Looks like Novartis chose OPTH for their wet macular degeneration partner.

http://online.wsj.com/news/articles/SB10001424052702304652804579572512748373716?mod=yahoo_hs&mg=reno64-wsj&url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB10001424052702304652804579572512748373716.html%3Fmod%3Dyahoo_hs

200 Million up front.

If ACTC has wet and dry and 20X the market including uveitis, myopathy, and retinosa pigmentosum... what do they get in an up front deal? 3 billion? lol.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up